Your browser doesn't support javascript.
loading
Prevalence of polyreactive innate clones among graft--infiltrating B cells in human cardiac allograft vasculopathy.
Chatterjee, Debanjana; Moore, Carolina; Gao, Baoshan; Clerkin, Kevin J; See, Sarah B; Shaked, David; Rogers, Kortney; Nunez, Sarah; Veras, Yokarla; Addonizio, Linda; Givertz, Michael M; Naka, Yoshifumi; Mancini, Donna; Vasilescu, Rodica; Marboe, Charles; Restaino, Susan; Madsen, Joren C; Zorn, Emmanuel.
Afiliación
  • Chatterjee D; Columbia Center for Translational Immunology, Columbia University Medical Center, New York, New York, USA.
  • Moore C; Massachusetts General Hospital Transplant Center, Center for Transplantation Science and Division of Cardiac Surgery, Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Gao B; Massachusetts General Hospital Transplant Center, Center for Transplantation Science and Division of Cardiac Surgery, Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA; Transplant Center, The First Hospital of Jilin University, Changchun, Ch
  • Clerkin KJ; Division of Cardiology, Department of Medicine, Columbia University Medical Center, New York, New York, USA.
  • See SB; Columbia Center for Translational Immunology, Columbia University Medical Center, New York, New York, USA.
  • Shaked D; Columbia Center for Translational Immunology, Columbia University Medical Center, New York, New York, USA.
  • Rogers K; Columbia Center for Translational Immunology, Columbia University Medical Center, New York, New York, USA.
  • Nunez S; Columbia Center for Translational Immunology, Columbia University Medical Center, New York, New York, USA.
  • Veras Y; Columbia Center for Translational Immunology, Columbia University Medical Center, New York, New York, USA.
  • Addonizio L; Division of Cardiothoracic Surgery, Department of Surgery, Columbia University Medical Center, New York, New York, USA.
  • Givertz MM; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Naka Y; Division of Cardiothoracic Surgery, Department of Surgery, Columbia University Medical Center, New York, New York, USA.
  • Mancini D; Division of Cardiology, Department of Medicine, Columbia University Medical Center, New York, New York, USA.
  • Vasilescu R; Department of Pathology & Cell Biology, Columbia University Medical Center, New York, New York, USA.
  • Marboe C; Department of Pathology & Cell Biology, Columbia University Medical Center, New York, New York, USA.
  • Restaino S; Division of Cardiology, Department of Medicine, Columbia University Medical Center, New York, New York, USA.
  • Madsen JC; Massachusetts General Hospital Transplant Center, Center for Transplantation Science and Division of Cardiac Surgery, Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
  • Zorn E; Columbia Center for Translational Immunology, Columbia University Medical Center, New York, New York, USA; Massachusetts General Hospital Transplant Center, Center for Transplantation Science and Division of Cardiac Surgery, Department of Surgery, Massachusetts General Hospital and Harvard Medical S
J Heart Lung Transplant ; 37(3): 385-393, 2018 03.
Article en En | MEDLINE | ID: mdl-29055600
ABSTRACT

BACKGROUND:

Cardiac allograft vasculopathy (CAV) has been associated with graft-infiltrating B cells, although their characteristics are still unclear. In this study we examined the frequency, localization and reactivity profile of graft-infiltrating B cells to determine their contribution to the pathophysiology of CAV.

METHODS:

B cells, plasma cells and macrophages were examined by immunohistochemistry in 56 allografts with CAV, 49 native failed hearts and 25 autopsy specimens. A total of 102 B-cell clones were immortalized directly from the infiltrates of 3 fresh cardiac samples with CAV. Their secreted antibodies were assessed using enzyme-linked immunoassay and flow cytometry.

RESULTS:

B-cell infiltration was observed around coronary arteries in 93% of allograft explants with CAV. Comparatively, intragraft B cells were less frequent and less dense in the intraventricular myocardium from where routine biopsies are obtained. Plasma cells and macrophages were also detected in 85% and 95% of explants, respectively. Remarkably, B-cell infiltrates were not associated with circulating donor-specific antibodies (DSA) or prior episodes of antibody-mediated rejection (AMR). Among all B-cell clones generated from 3 explants with CAV, a majority secreted natural antibodies reactive to multiple autoantigens and apoptotic cells, a characteristic of innate B cells.

CONCLUSIONS:

Our study reveals a high frequency of infiltrating B cells around the coronary arteries of allografts with CAV, independent of DSA or AMR. These cells are enriched for innate B cells with a polyreactive profile. The findings shift the focus from conventional DSA-producing B cells to the potentially pathogenic polyreactive B cells in the development of clinical CAV.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Complicaciones Posoperatorias / Enfermedad de la Arteria Coronaria / Linfocitos B / Trasplante de Corazón Tipo de estudio: Prevalence_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Complicaciones Posoperatorias / Enfermedad de la Arteria Coronaria / Linfocitos B / Trasplante de Corazón Tipo de estudio: Prevalence_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article